Amgen AMGN
NASDAQ AMGN
$424.94 -7.55 (-1.75%)
At close: Oct 19, 2026 · 4:00 PM EDT

Amgen (AMGN) Current Debt (2011 - 2017)

Updated

Amgen (AMGN) reported Current Debt of $540 million for Q3 2017.

Analysis

Amgen (AMGN) Current Debt (2011 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn -5.75 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn -
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn -
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn -
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn -
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 64.00 Mn
10 Vertex Pharmaceuticals 127.25 Bn 99.26 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 540.00 Mn
Dec 31, 2011 462.00 Mn
API Access

Amgen Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=AMGN&period=max&api_key=YOUR_API_KEY